Healthcare M&A remains stable. Outpatient models, digitalisation and scale define the next growth phase. Our Q3 update highlights key trends, valua...
Artikel lesenHealthcare M&A remains stable. Outpatient models, digitalisation and scale define the next growth phase. Our Q3 update highlights key trends, valua...
Artikel lesenThe contract pharma market is reshaping around scale, specialization, and regulatory trust. Swiss and DACH-based CROs/CDMOs are drawing strong inve...
Artikel lesenIn our MedTech M&A-Report, you will find updates on M&A activities and company valuations, current trends and an outlook on upcoming developments i...
Artikel lesenIn our MedTech M&A-Report, you will find updates on M&A activities and company valuations, current trends and an outlook on upcoming developments i...
Artikel lesen